ACTRN12610000574044尚未招募4 期
Proof-of-Concept Study of Insulin Glargine as Basal Insulin Support for patients with stress diabetes in the Intensive Care and the High Dependency Units and Validation of an Insulin Glargine Pharmacokinetics Model
Canterbury District Health Board/Christchurch Hospital0 个研究点目标入组 60 人开始时间: 2010年7月16日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- o limit 至 o limit（—）
- 性别
- All
入选标准
- •Stable hourly insulin requirement, equal to or less than 3U of intravenous insulin per hour, for at least 12 hours.
- •- Stable naso-gastric feed rate, equal to or greater than 60% of the calculated goal feed. (Goal feed is calculated using individual patient’s age, gender and frame size.)
- •- No acute renal failure (creatinine < 250 micromol/L)
- •- Less than 1000ml of fluid given as intravenous boluses in the past 24 hours, indicating stable interstitial volume.
- •- Resolving multiple organ failure (Sequential Organ Failure Assessment Score SOFA<=6).
排除标准
- •insulin dependent diabetes, absence of an arterial line, not expected to survive for more than 3 days at the time of screening
研究者
相似试验
撤回
4 期
A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participants With Type 2 DiabetesType 2 Diabetes Treated With InsulinType 2 DiabetesNCT04864977Eli Lilly and Company
进行中（未招募）
不适用
Comparative investigation of Insuline glargine versus Metformin as first line drug in treat-ment of early Type 2 Diabetes (GLORY) - GLORYDiabetes mellitus Type IIMedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusEUCTR2008-006860-12-DEGWT-TUD GmbH100
尚未招募
不适用
A Pilot Study To Clinically Evaluate InsuPress Wearable Injector In Patients With Type-I/II DiabetesCTRI/2022/06/043064Mediscient Devices OPC Pvt Ltd
进行中（未招募）
不适用
Estudio de superioridad de insulina glargina frente a sitagliptina en pacientes con diabetes tipo 2, sin experiencia previa de insulinoterapia, que reciben tratamiento con metformina y no están suficientemente controlados - EASIEDiabetes tipo 2 tratado con metformina y no suficientemente controladaMedDRA version: 9.1Level: LLTClassification code 10063624Term: Type II diabetes mellitus inadequate controlEUCTR2008-000516-32-ESsanofi aventis Groupe530
已完成
4 期
A STUDY OF BASAGINE™ IN LOCAL HEALTHY HUMAN SUBJECTS TO EVALUATE ITS PHARMACOKINETIC BEHAVIOURDiabetes mellitus.Diabetes mellitus Without complicationsE10-E14IRCT201203227978N2Getz Pharma (Pvt) Limited14